Back to Dividend Stocks
Zimmer Biomet Holdings, Inc. (ZBH) logo

Zimmer Biomet Holdings, Inc.

S&P 500
ZBH|Healthcare|Medical Devices|$82.33|P/E 21.3|MCap 15.9B|NYSE

Last update: May 9, 2026 at 09:32

Dividend Safety Rating

71/ 100Safe

ZBH's dividend appears safe and well-supported. Strengths include a 24.9% earnings payout ratio & 13.4% fcf payout ratio. Areas of concern: 6.1% return on equity & Volatile profit margin stability.

Based on 15 of 15 metrics

Strengths

  • Earnings Payout Ratio: 24.9%Low earnings payout ratio leaves room to grow the dividend.
  • FCF Payout Ratio: 13.4%Free cash flow comfortably covers the dividend.
  • CFO Payout Ratio: 11.9%Operating cash flow strongly supports the payout.

Risks

  • Return on Equity: 6.1%Return on equity is below industry norms.
  • Profit Margin Stability: VolatileProfit margins have been volatile.
  • 5-Year Dividend CAGR: 0.6%Dividend growth has been weak or negative.

Payout & Coverage

Very Safe
Earnings Payout Ratio
24.9%Very Safe
FCF Payout Ratio
13.4%Very Safe
CFO Payout Ratio
11.9%Very Safe
Interest Coverage
3.8xCaution

Balance Sheet

Safe
Net Debt / Total Assets
30.0%Caution
Current Ratio
1.7xSafe
Debt-to-Equity
59.8Safe

Profitability

Caution
Return on Equity
6.1%Warning
Operating Margin
19.7%Safe
Gross Margin
72.4%Very Safe
Profit Margin Stability
VolatileWarning

Dividend Track Record

Safe
Dividend Streak
11+ yrsVery Safe
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
0.6%Warning
Earnings Stability
Mostly StableCaution

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is a global medical technology company that designs, manufactures, and markets orthopedic reconstructive products for joint replacement and repair. The company provides a comprehensive portfolio including knee and hip implants, sports medicine and biologics products, extremities and trauma solutions, craniomaxillofacial and thoracic reconstructive products, spine implants, office-based surgical technologies, and dental implants. Zimmer Biomet serves patients, surgeons, and healthcare systems across multiple geographical markets including the Americas, Europe, Middle East, Africa, and Asia Pacific regions. The company has pursued strategic acquisitions and divestitures to strengthen its product lineup and expand its pipeline, demonstrating commitment to innovation in orthopedic solutions. With recent advancements including robotic-assisted surgical systems and iodine-treated implant technologies, Zimmer Biomet maintains a significant presence in the orthopedic reconstructive market. Founded in 1927 and headquartered in Warsaw, Indiana, the company operates as a key player in the medical device industry, focusing on improving musculoskeletal health outcomes globally.

Dividend Overview

Dividend Yield

1.17%

Annual Dividend

$0.96

Frequency

Quarterly

Payout Ratio

24.87%

FCF Payout Ratio

13.40%

Stock Price

$82.33

52-Week Range

$79.83 $108.29

Dividend History (2016–2025)

ZBH annual dividend per share and yield history

Earnings & Profitability

ZBH earnings per share and net profit margin

Key Dates

Last Ex-Dividend Date

March 31, 2026

Last Payment Date

April 30, 2026

Dividend Growth

3-Year Dividend CAGR

0.00%

5-Year Dividend CAGR

0.59%

10-Year Dividend CAGR

1.17%

3-Year Total Growth

0.00%

5-Year Total Growth

3.00%

10-Year Total Growth

12.36%

Income Calculator

ZBH Dividend Calculator

Total Investment

$8,233.00

Annual Income

$96.00

Quarterly Income

$24.00

Monthly Income

$8.00

Similar Dividend Stocks

StockYield5Y CAGRPrice
Zimmer Biomet Holdings, Inc. (ZBH) logo
ZBH
1.17%0.59%$82.33
Quest Diagnostics Inc. (DGX) logo
DGX
1.74%7.35%$187.39
Dexcom Inc. (DXCM) logo
DXCM
0.00%N/A$60.61
Incyte Corporation (INCY) logo
INCY
0.00%N/A$98.56
Labcorp Holdings Inc. (LH) logo
LH
1.13%N/A$254.12
Steris plc (STE) logo
STE
1.16%2.82%$207.45
Waters Corporation (WAT) logo
WAT
0.00%N/A$355.13
West Pharmaceutical Services, Inc. (WST) logo
WST
0.27%5.51%$325.92

Frequently Asked Questions

What is ZBH's current dividend yield?
Zimmer Biomet Holdings, Inc. (ZBH) currently has a dividend yield of 1.17%, based on a stock price of $82.33 and an annual dividend of $0.96.
When is ZBH's next dividend payment date?
ZBH's next ex-dividend date is 2026-03-31 and the next payment date is 2026-04-30. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does ZBH pay in dividends per year?
Zimmer Biomet Holdings, Inc. paid $0.96 per share in annual dividends in 2025. The dividends are paid quarterly.
Has ZBH been increasing its dividend?
Zimmer Biomet Holdings, Inc. has grown its dividend at a 5-year CAGR of 0.59% and a 10-year CAGR of 1.17%.
Is ZBH's dividend safe?
Zimmer Biomet Holdings, Inc. has a payout ratio of 24.87%. Its free cash flow payout ratio is 13.40%. A payout ratio below 60% is generally considered sustainable.
How is ZBH's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Zimmer Biomet Holdings, Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track ZBH Dividends with OnlyDividends

What will ZBH actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.